CGM Pharmacy Copay Program

MiniMed is committed to supporting access and addressing higher out-of-pocket costs.

MiniMed Champion Cameron pushing daughter on swing set with MiniMed 780g and Simplera Sync

Pay as little as $60 for a one-month supply of sensors

If you are commercially insured and have pharmacy benefit coverage for the MiniMed continuous glucose monitors (CGM), you may be eligible. This program applies to:

Instinct sensor, made by Abbott
Guardian^TM 4 sensor
Simplera Sync^TM sensor (for use with the MiniMed^TM 780G system)
Simplera^TMCGM (for use with the InPen^TM smart insulin pen system)

For the Guardian^TM 4 transmitter, pay as little as $99 per transmitter! Applicable one time per year.

How it works

If you have insurance coverage for the MiniMed CGM through your pharmacy benefit, and meet other eligiblity terms, the copay assistance will be automatically applied at the pharmacy.

Frequently asked questions

Who is eligible for the CGM Pharmacy Copay Program?

You may be eligible for this program if you meet the following requirements:

You have commercial health insurance.
You have a valid prescription for your MiniMed CGM from your healthcare professional.
You have coverage for CGMs under your health plan’s pharmacy benefit.

What if I’m not eligible for this program?

Eligibility is determined based on insurance coverage. You can call us at 800-646-4633 (Monday - Friday, 8 a.m. - 6 p.m. CT) to verify both your medical benefit for supplies and your pharmacy coverage to determine your lowest out-of-pocket cost. If you do not have any insurance coverage for the prescribed CGM, you may be eligible for other financial support programs from MiniMed.

How does the copay program work?

This copay support program will be automatically applied to your out-of-pocket balance due when you obtain the CGM through the MiniMed Pharmacy or other pharmacy within the vendor network.

Will the copay support be applied to my coinsurance or deductible as well?

This copay support would be applied to the amount you owe when the pharmacy claim is adjudicated.

Which products are included in this program?

This program is valid for: the Instinct sensor, Guardian^TM 4 sensor and transmitter, Simplera Sync^TM sensor, and Simplera^TM CGM.

CGM Pharmacy Copay Program Terms & Conditions

Valid prescription from provider required.
Eligible patients: Commercially insured patients only; with coverage through their pharmacy benefit.
Excluded participants include patients enrolled in any federal, state, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD) or TRICARE® that provides coverage for G4S, or where prohibited by law (including MA and MI).
If at any time a patient becomes enrolled under any such federal, state, or government-funded healthcare program, he/she will no longer be able to use this program and must call (858) 522-0252 to stop participation.
For the Guardian™ 4 sensor and transmitter: patients can receive up to a total of $500 maximum annual benefit for their annual transmitter. Patients can receive up to a total of $720 annual benefit for their sensors, with a monthly maximum benefit of $180 per month.
For the Instinct sensor, Simplera™ CGM, and Simplera Sync™ sensors: Patients can receive up to a total of $2000 annual benefit for their sensors, and a monthly maximum benefit of $380/month.
Program valid for eligible patients filling a prescription after December 13, 2024. There is no retroactive application of this program.
Customer agrees not to submit any claims for rebated products to any Government Plan and will not request their pharmacy or DME supplier to submit any such claim to any Government Plan.
Restrictions may apply. If the MiniMed CGM is not covered on your plans formulary, this program will not apply.
Offer and terms and conditions are subject to change or discontinue without notice.
This is not health insurance.
Offer good only in the USA at participating pharmacies and cannot be redeemed at government-subsidized clinics.

Important Safety Information: MiniMed^TM 780G system with SmartGuard^TMtechnology with Instinct sensor, Simplera Sync^TMsensor, and Guardian^TM4 sensor

The MiniMed^TM 780G system is intended for the continuous delivery of basal insulin at selectable rates and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose vales in the fluid under the skin.

The MiniMed^TM 780G System includes SmartGuard^TM technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera Sync^TM and Guardian^TM 4 sensors and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system. Discuss treatment decisions with your HCP.

WARNING: Do not use the SmartGuard^TMfeature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard^TMfeature.

WARNING: Do not use MiniMed^TM 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of MiniMed^TM 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard^TMfeature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed™ 780G system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including accessories and additional important safety information concerning indications, contraindications, warnings and precautions associated with the system and its components, please consult https://www.minimed.com/important-safety-information and the appropriate user guide at https://www.minimed.com/support/download-library.

©2026 MiniMed. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. ^TM*Third–party brands are trademarks of their respective owners.

DreaMed Diabetes is a trademark of DreaMed Diabetes, Ltd. The MiniMed^TM 780G system algorithm includes technology developed by DreaMed Diabetes.